News & Views

  • ERS Genomics and Fasmac Reach CRISPR/Cas9 Commercialisation Agreement for Japan
    Eric Rhodes

ERS Genomics and Fasmac Reach CRISPR/Cas9 Commercialisation Agreement for Japan

Oct 27 2020 Read 539 Times

ERS Genomics Ltd, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr Emmanuelle Charpentier, has announced it has signed an agreement with Fasmac Co, Ltd of Japan. Under the terms of the non-exclusive agreement Fasmac acquires the right to use CRISPR/Cas9 technology and commercialise tools and reagents associated with it. 

Established in 2001, Fasmac provides food analysis and biotechnology products and services including DNA/RNA synthesis products, DNA sequencing services, food testing services and genetic analysis reagents and kits.

"Our portfolio of Japanese companies taking license to the CRISPR/Cas9 technology is growing rapidly, and we are very pleased to be working with Fasmac," said Eric Rhodes, CEO of ERS Genomics. "We look forward to watching the company as it grows in this space and provides a valuable contribution to the genome editing field."

Dr Satoshi Futo, CEO of Fasmac commented: “Having access to advanced technologies such as CRISPR/Cas9 is very important to us, as we strive to create value for our customers both in Japan and overseas. The license from ERS will allow us to expand our already broad offering.”

Financial details of the agreement are not disclosed.

Reader comments

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.

Post a Comment





Digital Edition

Lab Asia December 2020

December 2020

In This Edition Articles - The Movement Towards More Comprehensive Testing of Mycotoxins in Cannabis - Addressing proper HACCP implementation - Micropatterning: The art of micro-controlling...

View all digital editions

Events

CISILE 2020 - NEW DATES

Dec 08 2020 Beijing, China

PHAR-EAST - NEW DATES

Dec 08 2020 VIrtual event

Nano Tech 2021 - NEW DATES

Dec 09 2020 Tokyo, Japan

Medical Fair Asia 2020 - NEW DATES

Dec 09 2020 Virtual event

View all events